Healthcare | May 08, 2026
Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
This is an exciting and meaningful milestone for GRIN Therapeutics
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Subscribe To Our Newsletter & Stay Updated
